SPRING BIOLAB AS
Operating
Utvikle og kommersialisere innovative metoder innen bioteknologi,
samt annet som står i forbindelse med dette. Videre er formålet å
investere i selskap som driver innen samme næring. Slike investeringer
skal godkjennes av selskapets generalforsamling med 2/3
(to-tredjedelers) flertall.
Utvikle og kommersialisere innovative metoder innen bioteknologi.
Investere i selskaper som driver innen samme næring.
Organization
- CEO
- SS
- Chairman of the board
- SS
- Years since formation
- 3 years
- since Nov 10, 2023
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 3,000
- 1 share class
- Total number of shareholders
- 3
- persons
Financials
- Total operating income 2025
- 196,307
- NOK
- Annual total result 2025
- 4,476
- NOK
- Total equity 2025
- 242,623
- NOK
Last update: May 19, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
SS | Managing Director/CEO | 90 % directly |
Board
| Name | Role | Shares |
|---|---|---|
SS | Chairman | 90 % directly |
HD 1981 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
SS | Chairman, Managing Director/CEO | 90 % directly |
GB 1947 | - | 9 % directly |
| - | 1 % directly |
Last update: Dec 16, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
SS | Ordinary shares | 2,700 | 90 % |
GB 1947 | Ordinary shares | 270 | 9 % |
| Ordinary shares | 30 | 1 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2023 |
|---|---|---|
Total operating income | 196,307 | 797,046 |
Annual Total Result | 4,476 | 213,717 |
Total assets | 363,952 | 342,827 |
Total liabilities | 121,329 | 104,680 |
Total equity | 242,623 | 238,147 |
P&L
| Year | 2025 | 2023 |
|---|---|---|
Total operating income | 196,307 | 797,046 |
Total operating costs | 195,114 | 577,321 |
Operating result | 1,193 | 219,725 |
Financial income/costs | 3,545 | -2,021 |
Profit before tax | 4,738 | 217,704 |
Total tax & extraordinary income/cost | 262 | 3,987 |
Annual Total Result | 4,476 | 213,717 |
Balance overview
| Year | 2025 | 2023 |
|---|---|---|
Total fixed assets | 0 | 0 |
Total current assets | 363,952 | 342,827 |
Total assets | 363,952 | 342,827 |
Short term debt | -1,432 | 104,680 |
Long term debt | 0 | 0 |
Total liabilities | 121,329 | 104,680 |
Contributed capital | 24,430 | 24,430 |
Retained earnings | 218,193 | 213,717 |
Total equity | 242,623 | 238,147 |
Total equity and liabilities | 363,952 | 342,827 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises